Combined with our current findings of an increasing trend of non‐PTLD DNMs, we may need to consciously push for cancer screening in post‐transplant patients.
← all excerpts
Chronological alterations in de novo malignancies after living-donor liver transplantation: A cohort study of 1781 recipients using annual comparisons of standardized incidence ratios.
1
—
—